VF
CYTK icon

Virtu Financial’s Cytokinetics CYTK Stock Holding History

Virtu Financial’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,433
Closed -$303K – 1490
2024
Q4 		$303K Buy
+6,433
New +$334K 0.02% 696
2024
Q1 		– Sell
-46,768
Closed -$3.9M – 1535
2023
Q4 		$3.9M Buy
+46,768
New +$1.69M 0.31% 42
2018
Q4 		– Sell
-11,271
Closed -$111K – 1625
2018
Q3 		$111K Buy
+11,271
New +$90.4K 0.01% 1175
2018
Q1 		– Sell
-13,720
Closed -$112K – 2058
2017
Q4 		$112K Buy
+13,720
New +$156K 0.01% 1877

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's CYTK Position: Q1 2025 in Review

Virtu Financial sold out of Cytokinetics (CYTK) in Q1 2025, closing a stake of 6,433 shares — an estimated $303K sold.

Virtu Financial first reported a position in CYTK in Q4 2017 and held it in 4 quarters. The position peaked at $3.9M in Q4 2023. 355 funds tracked by Wall St. Rank hold CYTK as of Q1 2025.

  • Virtu Financial reported no remaining Cytokinetics position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 6,433 Cytokinetics shares in Q1 2025, an estimated $303K.
  • Virtu Financial first reported a position in Cytokinetics in Q4 2017 and held it in 4 quarters.
  • Virtu Financial's Cytokinetics position peaked at $3.9M in Q4 2023.
  • 355 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.